AVENuE - Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
Phase of Trial: Phase II
Latest Information Update: 18 Nov 2019
Price : $35 *
At a glance
- Drugs Avelumab (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- Acronyms AVENuE
- 30 Sep 2019 Planned primary completion date changed from 1 Dec 2019 to 1 Oct 2020.
- 30 Sep 2019 Status changed from not yet recruiting to recruiting.
- 14 Aug 2018 New trial record